Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant
dc.contributor.author | Amin, H | |
dc.contributor.author | Jadavji, T | |
dc.contributor.author | Sauve, R | |
dc.contributor.author | Gill, J | |
dc.date.accessioned | 2018-09-27T12:33:16Z | |
dc.date.available | 2018-09-27T12:33:16Z | |
dc.date.issued | 1990-01-01 | |
dc.date.updated | 2018-09-27T12:33:16Z | |
dc.description.abstract | The first use of ganciclovir in a preterm infant is reported. The 27 week appropriate-for-gestational-age male infant developed a disseminated cytomegalovirus infection subsequent to a blood transfusion. A daily dose of 10 mg/kg administered intravenously in two divided doses for a total of 14 days was given without adverse clinical or toxic effects. The patient has remained well following discharge from hospital. | |
dc.description.version | Peer Reviewed | |
dc.identifier.citation | H Amin, T Jadavji, R Sauve, and J Gill, “Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant,” Canadian Journal of Infectious Diseases, vol. 1, no. 1, pp. 28-30, 1990. doi:10.1155/1990/917057 | |
dc.identifier.doi | https://doi.org/10.1155/1990/917057 | |
dc.identifier.uri | http://hdl.handle.net/1880/108666 | |
dc.identifier.uri | https://doi.org/10.11575/PRISM/44738 | |
dc.language.rfc3066 | en | |
dc.rights.holder | Copyright © 1990 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.title | Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant | |
dc.type | Journal Article |